Plasma homocysteine levels in patients with keratoconus

To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects. Thirty-three keratoconus patients, and 47 age-gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental optometry Vol. 103; no. 6; pp. 804 - 807
Main Authors Yilmaz, Mehmet, Arikan, Sedat, Türkön, Hakan
Format Journal Article
LanguageEnglish
Published Melbourne Taylor & Francis 01.11.2020
Wiley Publishing Asia Pty Ltd
Taylor & Francis Ltd
Subjects
Online AccessGet full text
ISSN0816-4622
1444-0938
1444-0938
DOI10.1111/cxo.13044

Cover

Abstract To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects. Thirty-three keratoconus patients, and 47 age-gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191-663-pg/mL, and 4.6-18.7-ng/mL respectively. Mann-Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively. There was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2-pg/ml in keratoconus patients versus 264.78 ± 94.2-pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2-ng/ml in keratoconus patients versus 6.72 ± 3.1-ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim-K (p = 0.002). The increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co-factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking.
AbstractList To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects. Thirty-three keratoconus patients, and 47 age-gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191-663 pg/mL, and 4.6-18.7 ng/mL respectively. Mann-Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively. There was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2 pg/ml in keratoconus patients versus 264.78 ± 94.2 pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2 ng/ml in keratoconus patients versus 6.72 ± 3.1 ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim-K (p = 0.002). The increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co-factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking.
To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.BACKGROUNDTo compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.Thirty-three keratoconus patients, and 47 age-gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191-663 pg/mL, and 4.6-18.7 ng/mL respectively. Mann-Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively.METHODSThirty-three keratoconus patients, and 47 age-gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191-663 pg/mL, and 4.6-18.7 ng/mL respectively. Mann-Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively.There was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2 pg/ml in keratoconus patients versus 264.78 ± 94.2 pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2 ng/ml in keratoconus patients versus 6.72 ± 3.1 ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim-K (p = 0.002).RESULTSThere was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2 pg/ml in keratoconus patients versus 264.78 ± 94.2 pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2 ng/ml in keratoconus patients versus 6.72 ± 3.1 ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim-K (p = 0.002).The increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co-factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking.CONCLUSIONSThe increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co-factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking.
Background To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects. Methods Thirty‐three keratoconus patients, and 47 age‐gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191–663 pg/mL, and 4.6–18.7 ng/mL respectively. Mann–Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively. Results There was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2 pg/ml in keratoconus patients versus 264.78 ± 94.2 pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2 ng/ml in keratoconus patients versus 6.72 ± 3.1 ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim‐K (p = 0.002). Conclusions The increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co‐factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking.
BackgroundTo compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.MethodsThirty‐three keratoconus patients, and 47 age‐gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191–663 pg/mL, and 4.6–18.7 ng/mL respectively. Mann–Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively.ResultsThere was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2 pg/ml in keratoconus patients versus 264.78 ± 94.2 pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2 ng/ml in keratoconus patients versus 6.72 ± 3.1 ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim‐K (p = 0.002).ConclusionsThe increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co‐factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking.
Author Arikan, Sedat
Yilmaz, Mehmet
Türkön, Hakan
Author_xml – sequence: 1
  givenname: Mehmet
  surname: Yilmaz
  fullname: Yilmaz, Mehmet
  organization: Ophthalmology Clinic, Hatay Antakya State Hospital
– sequence: 2
  givenname: Sedat
  surname: Arikan
  fullname: Arikan, Sedat
  organization: Department of Ophthalmology, Canakkale Onsekiz Mart University
– sequence: 3
  givenname: Hakan
  surname: Türkön
  fullname: Türkön, Hakan
  organization: Department of Medical Biochemistry, Canakkale Onsekiz Mart University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32036622$$D View this record in MEDLINE/PubMed
BookMark eNp1kE1LXDEUhoMoOn4s-gfKhW50cTUf535kWQarBUEXCu5CbkwwNjeZJrmdzr9vdGY2VrM5EJ73PYfnEO364DVCXwg-J-VdqL_hnDAMsINmBABqzFm_i2a4J20NLaUH6DClF4wpMA776IBRzNryP0PdnZNplNVzGINapayt15XTf7RLlfXVQmarfU7V0ubn6peOMgcV_JSO0Z6RLumTzTxCDz8u7-fX9c3t1c_595taMd5DDbjrqOESsDENpZ3qYdC0xcMg8dAZ3uB26AhIAG4YsF5J3tBe94NUHA-EsCN0uu5dxPB70imL0SalnZNehykJyhqGCfTQFfTbO_QlTNGX6wSFBghvCIFCfd1Q0zDqJ7GIdpRxJbZKCnCxBlQMKUVthLK5aAg-R2mdIFi8ShdFuniTXhJn7xLb0o_YTfvSOr36HBTzx9ttAtYJ602Io1yG6J5ElisXoonSK5sE-3_RPwrYoHY
CitedBy_id crossref_primary_10_1097_j_jcrs_0000000000001160
crossref_primary_10_1111_aos_14714
crossref_primary_10_12998_wjcc_v12_i18_3378
crossref_primary_10_3390_ijms241310790
crossref_primary_10_3390_nu14040913
Cites_doi 10.1097/IJG.0b013e31802d6942
10.1046/j.1442-9071.2001.d01-17.x
10.1046/j.1365-2362.2003.01189.x
10.1016/j.nbd.2006.06.010
10.1097/ICO.0b013e31822159f6
10.1371/journal.pone.0076333
10.1167/iovs.11-9268
10.1097/00003226-199403000-00003
10.3109/02713689209033483
10.3390/molecules21010012
10.1167/iovs.05-0828
10.1016/j.exer.2012.02.002
10.1167/iovs.14-14831
10.1111/j.1749-6632.1992.tb17100.x
10.1016/0026-0495(87)90043-6
10.1097/00003226-198803000-00001
10.1016/j.atherosclerosis.2004.06.015
10.1016/S0002-9394(02)02220-1
10.1167/iovs.08-2667
10.1007/s00702-013-0993-1
10.1016/j.exer.2012.09.005
10.1136/bjo.2008.144253
10.1159/000127832
10.1083/jcb.103.3.1121
10.1002/jcb.20137
10.1016/0003-9861(86)90105-0
ContentType Journal Article
Copyright 2020 Optometry Australia 2020
2020 Optometry Australia
2020 Optometry Australia.
Copyright_xml – notice: 2020 Optometry Australia 2020
– notice: 2020 Optometry Australia
– notice: 2020 Optometry Australia.
DBID AAYXX
CITATION
NPM
7TK
NAPCQ
7X8
DOI 10.1111/cxo.13044
DatabaseName CrossRef
PubMed
Neurosciences Abstracts
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Nursing & Allied Health Premium
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic


Nursing & Allied Health Premium
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1444-0938
EndPage 807
ExternalDocumentID 32036622
10_1111_cxo_13044
CXO13044
12124653
Genre Original Article
article
Journal Article
GrantInformation_xml – fundername: Research Projects Commission of Canakkale Onsekiz Mart University
  funderid: TTU‐2016‐998
GroupedDBID ---
.3N
.GA
05W
0BK
0R~
10A
1OB
1OC
24P
29B
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6J9
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AABVL
AAESR
AAEVG
AAMIU
AAONW
AAPUL
AAQRR
AAWTL
AAZKR
ABBKH
ABCQN
ABCUV
ABJNI
ABLIJ
ABPVW
ABXYU
ACENM
ACGFO
ACGFS
ACIEZ
ACMXC
ACNCT
ACPOU
ACPRK
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADXAS
ADZMN
AEIMD
AENEX
AEUQT
AFBPY
AFGKR
AFPWT
AGFJD
AGRBW
AGYJP
AIAGR
AIRBT
AIURR
AJAOE
AKBVH
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALYBC
AMBMR
AMDAE
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BHBCM
BMXJE
BROTX
BRXPI
BY8
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EMB
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
H13
HZI
HZ~
IX1
J0M
K48
LATKE
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LUTES
LYRES
M4Z
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RNANH
ROL
RVRKI
RX1
SUPJJ
SV3
TBQAZ
TDBHL
TEORI
TERGH
TFL
TR2
TUROJ
UB1
UEQFS
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
XG1
XSB
ZZTAW
~IA
~WT
.Y3
2WC
31~
AAHHS
AANHP
AAORF
ABEML
ABWCV
ACBWZ
ACCFJ
ACKZS
ACRPL
ACSCC
ACYXJ
ADFOM
ADNMO
ADZOD
AEEZP
AEIIZ
AEQDE
AFLEI
AFZJQ
AGDLA
AHEFC
AIWBW
AJBDE
AJVHN
ALQZU
ASPBG
AVWKF
AZFZN
BDRZF
C1A
CAG
COF
EJD
FEDTE
HF~
HVGLF
KTM
LW6
NUSFT
PALCI
RIWAO
RJQFR
WIN
WOQ
AAGDL
AAYXX
ABWVI
ADYSH
AFRVT
AMPGV
CITATION
NPM
7TK
NAPCQ
7X8
ID FETCH-LOGICAL-c3984-40772f9a40ff5227c84be260bba0b7f9506b714a449f3438ca9528e8bac90b113
IEDL.DBID DR2
ISSN 0816-4622
1444-0938
IngestDate Thu Sep 04 16:58:35 EDT 2025
Fri Jul 25 07:20:24 EDT 2025
Wed Feb 19 02:29:03 EST 2025
Tue Jul 01 02:59:20 EDT 2025
Thu Apr 24 23:05:16 EDT 2025
Wed Jan 22 16:31:39 EST 2025
Wed Dec 25 09:08:01 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords homocysteine
vitamin B12
keratoconus
folic acid
plasma
Language English
License 2020 Optometry Australia.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3984-40772f9a40ff5227c84be260bba0b7f9506b714a449f3438ca9528e8bac90b113
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 32036622
PQID 2454195114
PQPubID 2045178
PageCount 4
ParticipantIDs proquest_miscellaneous_2353014847
wiley_primary_10_1111_cxo_13044_CXO13044
proquest_journals_2454195114
crossref_citationtrail_10_1111_cxo_13044
informaworld_taylorfrancis_310_1111_cxo_13044
pubmed_primary_32036622
crossref_primary_10_1111_cxo_13044
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 11/1/2020
November 2020
2020-11-01
2020-11-00
20201101
PublicationDateYYYYMMDD 2020-11-01
PublicationDate_xml – month: 11
  year: 2020
  text: 11/1/2020
  day: 01
PublicationDecade 2020
PublicationPlace Melbourne
PublicationPlace_xml – name: Melbourne
– name: Australia
– name: Chichester
PublicationTitle Clinical and experimental optometry
PublicationTitleAlternate Clin Exp Optom
PublicationYear 2020
Publisher Taylor & Francis
Wiley Publishing Asia Pty Ltd
Taylor & Francis Ltd
Publisher_xml – name: Taylor & Francis
– name: Wiley Publishing Asia Pty Ltd
– name: Taylor & Francis Ltd
References 1987; 36
2015; 56
2013; 4
2013; 120
2001; 29
2013; 7
2012; 104
1992; 11
2003; 135
2014; 130
2012; 31
2012; 53
2003; 33
2001; 42
1992; 30
2007; 16
2004; 177
1986; 103
2004; 93
2006; 23
1986; 244
2009; 50
2009; 93
2006; 47
1988; 7
2015; 21
1997; 38
1994; 13
2008; 40
Kolozsvari BL (CIT0019) 2013; 4
CIT0030
Raposo B (CIT0010) 2004; 177
Roedl JB (CIT0029) 2008; 40
Smolek MK (CIT0002) 1997; 38
CIT0014
Coral K (CIT0020) 2009; 50
CIT0016
CIT0015
CIT0018
CIT0017
Vazirani J (CIT0001) 2013; 7
Holven KB (CIT0024) 2003; 33
CIT0021
CIT0023
Kang SS (CIT0012) 1987; 36
Avetisov SE (CIT0013) 2014; 130
Mason JB (CIT0011) 1992; 30
CIT0003
Sethi A (CIT0022) 2012; 104
CIT0025
Behndig A (CIT0028) 2001; 42
CIT0005
CIT0027
CIT0004
CIT0026
CIT0007
CIT0006
CIT0009
CIT0008
References_xml – volume: 31
  start-page: 227
  year: 2012
  end-page: 231
  article-title: Riboflavin‐UVA‐induced corneal collagen cross‐linking in pediatric patients
  publication-title: Cornea
– volume: 29
  start-page: 340
  year: 2001
  end-page: 344
  article-title: Is the corneal degradation in keratoconus caused by matrix‐metalloproteinases?
  publication-title: Clin Exp Ophthalmol
– volume: 56
  start-page: 738
  year: 2015
  end-page: 750
  article-title: Elevated expression of matrix metalloproteinase‐9 and inflammatory cytokines in keratoconus patients is inhibited by cyclosporine A
  publication-title: Invest Ophthalmol Vis Sci
– volume: 7
  start-page: 163
  year: 1988
  end-page: 169
  article-title: Keratoconus
  publication-title: Cornea
– volume: 36
  start-page: 458
  year: 1987
  end-page: 462
  article-title: Homocysteinemia due to folate deficiency
  publication-title: Metabolism
– volume: 93
  start-page: 207
  year: 2004
  end-page: 213
  article-title: Homocysteine induces metalloproteinase and shedding of beta‐1 integrin in microvessel endothelial cells
  publication-title: J Cell Biochem
– volume: 16
  start-page: 234
  year: 2007
  end-page: 239
  article-title: Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma
  publication-title: J Glaucoma
– volume: 120
  start-page: 977
  year: 2013
  end-page: 982
  article-title: The impairment of lysyl oxidase in keratoconus and in keratoconus‐associated disorders
  publication-title: J Neural Transm
– volume: 23
  start-page: 725
  year: 2006
  end-page: 730
  article-title: Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY‐5Y cells
  publication-title: Neurobiol Dis
– volume: 42
  start-page: 2293
  year: 2001
  end-page: 2296
  article-title: Superoxide dismutase isoenzymes in the normal and diseased human cornea
  publication-title: Invest Ophthalmol Vis Sci
– volume: 38
  start-page: 1289
  year: 1997
  end-page: 1290
  article-title: Collagen fibril orientation in the human corneal stroma and its implications in keratoconus
  publication-title: Invest Ophthalmol Vis Sci
– volume: 104
  start-page: 74
  year: 2012
  end-page: 81
  article-title: Changes in lysyl oxidase (LOX) distribution and its decreased activity in keratoconus corneas
  publication-title: Exp Eye Res
– volume: 103
  start-page: 1121
  year: 1986
  end-page: 1128
  article-title: Ultrastructural immunolocalization of lysyl oxidase in vascular connective tissue
  publication-title: J Cell Biol
– volume: 33
  start-page: 555
  year: 2003
  end-page: 560
  article-title: Expression of matrix metalloproteinase‐9 in mononuclear cells of hyperhomocysteinaemic subjects
  publication-title: Eur J Clin Invest
– volume: 93
  start-page: 820
  year: 2009
  end-page: 824
  article-title: Subclinical keratoconus and inflammatory molecules from tears
  publication-title: Br J Ophthalmol
– volume: 104
  start-page: 97
  year: 2012
  end-page: 98
  article-title: Focus on molecules: lysyl oxidase
  publication-title: Exp Eye Res
– volume: 7
  start-page: 2019
  year: 2013
  end-page: 2030
  article-title: Keratoconus: current perspectives
  publication-title: Clin Ophthalmol
– volume: 4
  year: 2013
  article-title: Alterations of tear mediators in patients with keratoconus after corneal crosslinking associate with corneal changes
  publication-title: PLoS One
– volume: 47
  start-page: 1902
  year: 2006
  end-page: 1910
  article-title: Increased stress‐induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts
  publication-title: Invest Ophthalmol Vis Sci
– volume: 177
  start-page: 1
  year: 2004
  end-page: 8
  article-title: High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells
  publication-title: Atherosclerosis
– volume: 30
  start-page: 197
  year: 1992
  end-page: 203
  article-title: The effects of vitamins B12, B6, and folate on blood homocysteine levels
  publication-title: Ann N Y Acad Sci
– volume: 244
  start-page: 161
  year: 1986
  end-page: 168
  article-title: Role of plasma and serum proteases in the degradation of elastin
  publication-title: Arch Biochem Biophys
– volume: 21
  start-page: 12
  year: 2015
  end-page: 25
  article-title: Attenuation of lysyl oxidase and collagen gene expression in keratoconus patient corneal epithelium corresponds to disease severity
  publication-title: Mol Vis
– volume: 13
  start-page: 114
  year: 1994
  end-page: 124
  article-title: Increased gelatinolytic activity in keratoconus keratocyte cultures. A correlation to an altered matrix metalloproteinase‐2/tissue inhibitor of metalloproteinase ratio
  publication-title: Cornea
– volume: 135
  start-page: 620
  year: 2003
  end-page: 627
  article-title: Riboflavin/ultraviolet‐A‐induced collagen crosslinking for the treatment of keratoconus
  publication-title: Am J Ophthalmol
– volume: 40
  start-page: 249
  year: 2008
  end-page: 256
  article-title: Increased homocysteine levels in tear fluid of patients with primary open‐angle glaucoma
  publication-title: Ophthalmic Res
– volume: 130
  start-page: 110
  year: 2014
  end-page: 116
  article-title: Keratoconus: etiological factors and accompanying manifestations
  publication-title: Vestn Oftalmol
– volume: 50
  start-page: 3607
  year: 2009
  end-page: 3612
  article-title: Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase
  publication-title: Invest Ophthalmol Vis Sci
– volume: 53
  start-page: 4152
  year: 2012
  end-page: 4157
  article-title: Variation in the lysyl oxidase (LOX) gene is associated with keratoconus in family‐based and case‐control studies
  publication-title: Invest Ophthalmol Vis Sci
– volume: 11
  start-page: 849
  year: 1992
  end-page: 862
  article-title: Collagenolytic/gelatinolytic mettaloproteinases in normal and keratoconus corneas
  publication-title: Curr Eye Res
– ident: CIT0030
  doi: 10.1097/IJG.0b013e31802d6942
– ident: CIT0017
  doi: 10.1046/j.1442-9071.2001.d01-17.x
– volume: 33
  start-page: 555
  year: 2003
  ident: CIT0024
  publication-title: Eur J Clin Invest
  doi: 10.1046/j.1365-2362.2003.01189.x
– ident: CIT0021
  doi: 10.1016/j.nbd.2006.06.010
– ident: CIT0007
  doi: 10.1097/ICO.0b013e31822159f6
– volume: 130
  start-page: 110
  year: 2014
  ident: CIT0013
  publication-title: Vestn Oftalmol
– volume: 4
  start-page: e76333
  year: 2013
  ident: CIT0019
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0076333
– ident: CIT0015
  doi: 10.1167/iovs.11-9268
– ident: CIT0004
  doi: 10.1097/00003226-199403000-00003
– volume: 42
  start-page: 2293
  year: 2001
  ident: CIT0028
  publication-title: Invest Ophthalmol Vis Sci
– ident: CIT0003
  doi: 10.3109/02713689209033483
– ident: CIT0016
  doi: 10.3390/molecules21010012
– ident: CIT0027
  doi: 10.1167/iovs.05-0828
– volume: 104
  start-page: 97
  year: 2012
  ident: CIT0022
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2012.02.002
– ident: CIT0026
  doi: 10.1167/iovs.14-14831
– volume: 30
  start-page: 197
  year: 1992
  ident: CIT0011
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.1992.tb17100.x
– volume: 36
  start-page: 458
  year: 1987
  ident: CIT0012
  publication-title: Metabolism
  doi: 10.1016/0026-0495(87)90043-6
– ident: CIT0005
  doi: 10.1097/00003226-198803000-00001
– volume: 177
  start-page: 1
  year: 2004
  ident: CIT0010
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2004.06.015
– volume: 38
  start-page: 1289
  year: 1997
  ident: CIT0002
  publication-title: Invest Ophthalmol Vis Sci
– ident: CIT0006
  doi: 10.1016/S0002-9394(02)02220-1
– volume: 50
  start-page: 3607
  year: 2009
  ident: CIT0020
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.08-2667
– ident: CIT0009
  doi: 10.1007/s00702-013-0993-1
– ident: CIT0014
  doi: 10.1016/j.exer.2012.09.005
– ident: CIT0025
  doi: 10.1136/bjo.2008.144253
– volume: 7
  start-page: 2019
  year: 2013
  ident: CIT0001
  publication-title: Clin Ophthalmol
– volume: 40
  start-page: 249
  year: 2008
  ident: CIT0029
  publication-title: Ophthalmic Res
  doi: 10.1159/000127832
– ident: CIT0008
  doi: 10.1083/jcb.103.3.1121
– ident: CIT0023
  doi: 10.1002/jcb.20137
– ident: CIT0018
  doi: 10.1016/0003-9861(86)90105-0
SSID ssj0024394
Score 2.249375
Snippet To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects. Thirty-three keratoconus patients, and 47 age-gender...
Background To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects. Methods Thirty‐three keratoconus patients, and...
BackgroundTo compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.MethodsThirty‐three keratoconus patients, and 47...
To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.BACKGROUNDTo compare the plasma levels of homocysteine...
SourceID proquest
pubmed
crossref
wiley
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 804
SubjectTerms Chemiluminescence
Collagen
Cornea
Correlation analysis
Folic acid
Homocysteine
Keratoconus
Lysyl oxidase
Oxidative stress
Plasma
Plasma levels
Statistical analysis
Vitamin B
Vitamin B12
Title Plasma homocysteine levels in patients with keratoconus
URI https://www.tandfonline.com/doi/abs/10.1111/cxo.13044
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcxo.13044
https://www.ncbi.nlm.nih.gov/pubmed/32036622
https://www.proquest.com/docview/2454195114
https://www.proquest.com/docview/2353014847
Volume 103
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7LHsSL78f6oooHL12aNmkbPMnqsgg-EIU9CCXJpihqK3YXxF_vTPpgV1YQb6WZwiSZ6XyTxzeEHKecphCIqcsjNnKZjJgrtPFcw7mOIYIJY7k7r67DwQO7HPJhi5zWd2FKfohmwQ09w_6v0cGlKqacXH_mWMqYIRcoDULkzT-_86d49mwRRKwr4bLQ9ytWITzF03w5E4tmmErn4c1Z-GrjT3-ZPNaal8dOXrqTserqrx-kjv_s2gpZqnCpc1Ya0ippmWyNLFxVO-_rJLoFmP0mnaf8LdfI_gxvnVc8cVQ4z5lT0bMWDq7rOi_I1JxDpj0pNshD_-K-N3CroguuDkTMIJ8EvJ0Kybw0BWwW6ZgpA0mPUtJTUSq4F6qIMsmYSAMWxFoK7scmVlILT1EabJJ2lmdmmzjUiJHmjI6Ql80zoeBxGIfUhJ5U1NesQ07q4U90xUiOhTFekzozgYFI7EB0yFEj-l7ScMwTcqfnMBnbNY-0LFCSBHPk9-pJTirPLRKfgcYAOyk0HzbN4HO4kSIzk09AJuCYiUJg75Ct0jgarQLc2QV7g87ZKf5d3aQ3vLEPO38X3SWLPib89jLkHmmPPyZmH1DRWB1Y8_8GUk8FYA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9qBfWl9duzVaP44EtKNplNsuCLVMupvSrSwr3Isru3QWmbiHcHxb_emc0Hd3KC-BayE5j9mMxvZnd_A_CykqIiRyxiWeAsRlNgrJxPYi-lK8mDKR-4Oycn-fgMP0zldAte93dhWn6IIeHGlhH-12zgnJBesXJ31XAtY8RrcB0JaHDo9fZLusK0F8ogcmWJGPM07XiF-BzP8OmaN1rjKt2EONcBbPBAR7vwtde9PXhyfrBc2AP36w9ax__t3G3Y6aBp9KZdS3dgy9d34cak23y_B8VnQtqXJvrWXDaOCaDpbXTBh47m0fc66hha5xGndqNzJmtuKNhezu_D2dG708Nx3NVdiF2mSqSQkiB3pQwmVUXwrHAlWk9xj7UmsUWlZJLbQqBBVFWGWemMkmnpS2ucSqwQ2QPYrpvaP4JIeDVzEsWMqdkSnytZ5mUufJ4YK1KHI3jVj792HSk518a40H1wQgOhw0CM4MUg-qNl4tgkFK9Ool6EtEfV1ijR2Qb5_X6WdWe8c50iaUzIU1Dz86GZzI73UkztmyXJZJKDUfLtI3jYro5Bq4w3d2nBUefCHP9dXX04_RQeHv-76DO4OT6dHOvj9ycf9-BWyvF_uBu5D9uLn0v_hEDSwj4NtvAbrY4Jfw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SBEIvefSVTdLWLT304mDZI9uip5J0SR9JQ2lgDwUhaSUaktghuwshvz4j-cFu2ULpzVhjGI00nm_0-AbgnePMUSBmMS9wHKMqMBbGJrHl3JQUwYQN3J0np_nxOX4Z8dEKfOjuwjT8EP2Cm_eM8L_2Dn4zdnNObu5qX8oY8RGsYU5IwiOiH-kc0V6ogugLS8SYp2lLK-SP8fSfLgSjBarSZYBzEb-GADTchF-d6s25k8uD2VQfmPs_WB3_s29bsNEC0-hjM5O2YcVWT2D9pN16fwrFGeHsaxX9rq9r4-mf6W105Y8cTaKLKmr5WSeRX9iNLj1Vc02p9mzyDM6Hn34eHsdt1YXYZKJESigJcDuhMHGOwFlhStSWsh6tVaILJ3iS64KhQhQuw6w0SvC0tKVWRiSasew5rFZ1ZXcgYlaMDUc29sRsic0FL_MyZzZPlGapwQG878wvTUtJ7itjXMkuNSFDyGCIAbztRW8aHo5lQvH8GMppWPRwTYUSmS2R3-8GWbauO5EpksaEOxk1v-mbyen8ToqqbD0jmYz7VJQi-wBeNJOj1yrzW7s036hzYYj_rq48HH0PD7v_Lvoa1s-OhvLb59Ove_A49cl_uBi5D6vT25l9SQhpql8FT3gAiZoILg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+homocysteine+levels+in+patients+with+keratoconus&rft.jtitle=Clinical+and+experimental+optometry&rft.au=Yilmaz%2C+Mehmet&rft.au=Arikan%2C+Sedat&rft.au=T%C3%BCrk%C3%B6n%2C+Hakan&rft.date=2020-11-01&rft.eissn=1444-0938&rft.volume=103&rft.issue=6&rft.spage=804&rft_id=info:doi/10.1111%2Fcxo.13044&rft_id=info%3Apmid%2F32036622&rft.externalDocID=32036622
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0816-4622&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0816-4622&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0816-4622&client=summon